期刊文献+

肥胖患者脂肪激素与代谢综合征的研究进展 被引量:3

The Research Progress of Adipose Hormone in Obesity Patients and Metabolic Syndrome
下载PDF
导出
摘要 代谢综合征是指伴有胰岛素抵抗的一组疾病的丛集,包括腹部肥胖症、血糖升高、血脂异常以及高血压。其表现为直接促进动脉粥样硬化性心血管疾病的发展。脂肪激素在代谢综合征的发生、发展中发挥了重要作用。世界范围内肥胖人群数量增加促使人们对脂肪激素的研究越来越深入,这为探讨代谢综合征的机制及治疗提供了理论依据。 Metabolic syndrome is a group of diseases associated with insulin resistance, including abdominal obesity, hyperglycemia, dyslipidemia and hypertension. It directly promotes atherosclerotic cardiovascular disease development. The adipose hormone plays an important role in the occurrence and development of metabolic syndrome. The increasing number of worldwide obesity patients impels people to conduct more research on the adipose hormone deeply, which provides the theoretical basis to investigate the mechanism and treatment of metabolic syndrome.
作者 刘军 陈小霞
出处 《医学综述》 2015年第23期4323-4325,共3页 Medical Recapitulate
关键词 肥胖 代谢综合征 胰岛素抵抗 脂肪激素 Obesity Metabolic syndrome Insulin resistance Adipose hormone
  • 相关文献

参考文献21

  • 1Garg PK, Biggs ML, Camethon M, et al. Metabolic syndrome andrisk of incident peripheral artery disease : the cardiovascular healthstudy[ J]. Hypertension,2014,63 (2) :413-419.
  • 2Yamanaka T,Fukuda T,Shirota S,et al. Theprevalence and charac-teristics of metabolic syndrome in patients with vertigo [ J ]. PLoSOne,2013,8(12) :e80176.
  • 3Makimura H,Feldpausch MN,Rope AM,et al. Metabolic effects ofa growth hormone-releasing factor in obese subjects with reducedgrowth hormone secretion: a randomized controlled trial[ J]. ClinEndocrinol Metah ,2012 ,97 (12 ) :47694779.
  • 4Reaven GM. Banting lecture 1988. Role of insulin resistance inhuman disease[ J]. Diabetes, 1988 ,37 ( 12) : 1595-1607.
  • 5Dunstan DW, Daly RM, Owen N, et al. Home-based resistancetraining is not sufficient to maintain improved glycemic controlfollowing supervised training in older individuals with type 2 diabe-tes[J]. Diabetes Care,2005,28(1) :3-9.
  • 6Robertson MD, Wright JW, Loizon E,et al. Insulin-sensitizingeffects on muscle and adipose tissue after dietary fiber intake inmen and women with metabolic syndrome [ J]. J Clin EndocrinolMetab,2012,97(9) :3326-3332.
  • 7Oranski SP,Eliseeva LN,Khanfetian RA. Body structure and serumconcentration of adiponectin and cytokines ( IL-6,-10 and TNF-alpha) in rheumatoid arthritis combined with obesity [ J ]. VoprPitan,2013,82(4) :1044.
  • 8Calvani M,Scaifone A,Granato L,e. al. Restoration of adiponectinpulsatility in severely obese subjects after weight loss[ J]. Diabe-tes,2004,53(4) :939-947.
  • 9Shah AS,Dolan LM,Lauer A,et al. Adiponectin and arterial stiff-ness in youth with type 1 diabetes : the SEARCH for diabetes inyouth study [ J ]. Pediatr Endocrinol Metab, 2012, 25 ( 7/8 ):717-721.
  • 10Holguin F,Rojas M,Hart CM. The peroxisome proliferator activatedreceptor gamma ( PPARgamma) ligand rosiglitazone modulatesbronchoalveolar lavage levels of leptin,adiponectin,and inflamma-tory cytokines in lean and obese mice [ J]. Lung,2007,185 (6):367-372.

同被引文献35

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部